The objective of this study was toevaluate the role of aspirin in reducing the incidence of breast cancer and toevaluate the impact of its use on morbidity and mortality and reduction ofcardiovascular events as adjuvant therapy during breast cancer treatment withselective estrogen receptor modulators. Here, ESR1 is linked to breast carcinoma.